A study on the AMACR catalysed elimination reaction and its application to inhibitor testing

Maksims Jevglevskis, Guat Ling Lee, Jenny Sun, Shiyi Zhou, Xiaolong Sun, Gabriele Kociok-Kohn, Tony D. James, Timothy J. Woodman, Matthew David Lloyd

Research output: Contribution to journalArticle

8 Citations (Scopus)
53 Downloads (Pure)

Abstract

α-Methylacyl-CoA racemase (AMACR; P504S) catalyses a key step in the degradation of branched-chain fatty acids and is important for the pharmacological activation of Ibuprofen and related drugs. Levels of the enzyme are increased in prostate and other cancers, and it is a drug target. Development of AMACR as a drug target is hampered by lack of a convenient assay. AMACR irreversibly catalyses the elimination of HF from 3-fluoro-2-methylacyl-CoA substrates, and this reaction was investigated for use as an assay. Several known inhibitors and alternative substrates reduced substrate conversion by AMACR, as determined by 1H NMR. The greatest reduction of activity was observed for known potent inhibitors. A series of novel acyl-CoA esters with aromatic side chains were synthesised for testing as chromophoric substrates. These acyl-CoA esters were converted to unsaturated products by AMACR, but their use was limited by non-enzymatic elimination. Fluoride sensors were also investigated as a method of quantifying released fluoride and thus AMACR activity. These sensors generally suffered from high background signal and lacked reproducibility under the assay conditions. In summary, the elimination reaction can be used to characterise inhibitors, but it was not possible to develop a convenient colorimetric or fluorescent assay using 3-fluoro-2-methylacyl-CoA substrates.
Original languageEnglish
Pages (from-to)612-622
JournalOrganic and Biomolecular Chemistry
Volume14
Issue number2
Early online date27 Oct 2015
DOIs
Publication statusPublished - Jan 2016

Fingerprint

inhibitors
elimination
Acyl Coenzyme A
Coenzyme A
Assays
Fluorides
Esters
Testing
Substrates
drugs
Pharmaceutical Preparations
Ibuprofen
fluorides
esters
Prostatic Neoplasms
Fatty Acids
Pharmacology
sensors
Sensors
fatty acids

Keywords

  • AMACR, prostate cancer, fluoride, fluorescent sensor

Cite this

A study on the AMACR catalysed elimination reaction and its application to inhibitor testing. / Jevglevskis, Maksims; Lee, Guat Ling; Sun, Jenny; Zhou, Shiyi; Sun, Xiaolong; Kociok-Kohn, Gabriele; James, Tony D.; Woodman, Timothy J.; Lloyd, Matthew David.

In: Organic and Biomolecular Chemistry, Vol. 14, No. 2, 01.2016, p. 612-622.

Research output: Contribution to journalArticle

@article{65124bd218df4a6a81e6dfda7223c367,
title = "A study on the AMACR catalysed elimination reaction and its application to inhibitor testing",
abstract = "α-Methylacyl-CoA racemase (AMACR; P504S) catalyses a key step in the degradation of branched-chain fatty acids and is important for the pharmacological activation of Ibuprofen and related drugs. Levels of the enzyme are increased in prostate and other cancers, and it is a drug target. Development of AMACR as a drug target is hampered by lack of a convenient assay. AMACR irreversibly catalyses the elimination of HF from 3-fluoro-2-methylacyl-CoA substrates, and this reaction was investigated for use as an assay. Several known inhibitors and alternative substrates reduced substrate conversion by AMACR, as determined by 1H NMR. The greatest reduction of activity was observed for known potent inhibitors. A series of novel acyl-CoA esters with aromatic side chains were synthesised for testing as chromophoric substrates. These acyl-CoA esters were converted to unsaturated products by AMACR, but their use was limited by non-enzymatic elimination. Fluoride sensors were also investigated as a method of quantifying released fluoride and thus AMACR activity. These sensors generally suffered from high background signal and lacked reproducibility under the assay conditions. In summary, the elimination reaction can be used to characterise inhibitors, but it was not possible to develop a convenient colorimetric or fluorescent assay using 3-fluoro-2-methylacyl-CoA substrates.",
keywords = "AMACR, prostate cancer, fluoride, fluorescent sensor",
author = "Maksims Jevglevskis and Lee, {Guat Ling} and Jenny Sun and Shiyi Zhou and Xiaolong Sun and Gabriele Kociok-Kohn and James, {Tony D.} and Woodman, {Timothy J.} and Lloyd, {Matthew David}",
year = "2016",
month = "1",
doi = "10.1039/C5OB01541C",
language = "English",
volume = "14",
pages = "612--622",
journal = "Organic and Biomolecular Chemistry",
issn = "1477-0520",
publisher = "Royal Society of Chemistry",
number = "2",

}

TY - JOUR

T1 - A study on the AMACR catalysed elimination reaction and its application to inhibitor testing

AU - Jevglevskis, Maksims

AU - Lee, Guat Ling

AU - Sun, Jenny

AU - Zhou, Shiyi

AU - Sun, Xiaolong

AU - Kociok-Kohn, Gabriele

AU - James, Tony D.

AU - Woodman, Timothy J.

AU - Lloyd, Matthew David

PY - 2016/1

Y1 - 2016/1

N2 - α-Methylacyl-CoA racemase (AMACR; P504S) catalyses a key step in the degradation of branched-chain fatty acids and is important for the pharmacological activation of Ibuprofen and related drugs. Levels of the enzyme are increased in prostate and other cancers, and it is a drug target. Development of AMACR as a drug target is hampered by lack of a convenient assay. AMACR irreversibly catalyses the elimination of HF from 3-fluoro-2-methylacyl-CoA substrates, and this reaction was investigated for use as an assay. Several known inhibitors and alternative substrates reduced substrate conversion by AMACR, as determined by 1H NMR. The greatest reduction of activity was observed for known potent inhibitors. A series of novel acyl-CoA esters with aromatic side chains were synthesised for testing as chromophoric substrates. These acyl-CoA esters were converted to unsaturated products by AMACR, but their use was limited by non-enzymatic elimination. Fluoride sensors were also investigated as a method of quantifying released fluoride and thus AMACR activity. These sensors generally suffered from high background signal and lacked reproducibility under the assay conditions. In summary, the elimination reaction can be used to characterise inhibitors, but it was not possible to develop a convenient colorimetric or fluorescent assay using 3-fluoro-2-methylacyl-CoA substrates.

AB - α-Methylacyl-CoA racemase (AMACR; P504S) catalyses a key step in the degradation of branched-chain fatty acids and is important for the pharmacological activation of Ibuprofen and related drugs. Levels of the enzyme are increased in prostate and other cancers, and it is a drug target. Development of AMACR as a drug target is hampered by lack of a convenient assay. AMACR irreversibly catalyses the elimination of HF from 3-fluoro-2-methylacyl-CoA substrates, and this reaction was investigated for use as an assay. Several known inhibitors and alternative substrates reduced substrate conversion by AMACR, as determined by 1H NMR. The greatest reduction of activity was observed for known potent inhibitors. A series of novel acyl-CoA esters with aromatic side chains were synthesised for testing as chromophoric substrates. These acyl-CoA esters were converted to unsaturated products by AMACR, but their use was limited by non-enzymatic elimination. Fluoride sensors were also investigated as a method of quantifying released fluoride and thus AMACR activity. These sensors generally suffered from high background signal and lacked reproducibility under the assay conditions. In summary, the elimination reaction can be used to characterise inhibitors, but it was not possible to develop a convenient colorimetric or fluorescent assay using 3-fluoro-2-methylacyl-CoA substrates.

KW - AMACR, prostate cancer, fluoride, fluorescent sensor

UR - http://dx.doi.org/10.1039/C5OB01541C

U2 - 10.1039/C5OB01541C

DO - 10.1039/C5OB01541C

M3 - Article

VL - 14

SP - 612

EP - 622

JO - Organic and Biomolecular Chemistry

JF - Organic and Biomolecular Chemistry

SN - 1477-0520

IS - 2

ER -